Esperion Therapeutics | ESPR - Ebit

سعر السهم
2.59
التغيير اليومي
0.04 1.37%
شهريا
-21.67%
سنويا
48.56%
Q1 التوقعات
2.47




Ebit تغيير تاريخ
AbbVie USD 5.81B 4.36B 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cipla INR 9.77B 6.21B 2025-12
CSL USD 2.64B 116M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Geron USD -10.79M 3.1M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12